Tempus AI, Inc Class A Common Stock

Yahoo Finance • 4 days ago

Tempus AI, Inc. (TEM): A Bull Case Theory

We came across a bullish thesis on Tempus AI, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on TEM. Tempus AI, Inc.'s share was trading at $77.33 as of September 25th. TEM’s trailin... Full story

Yahoo Finance • 13 days ago

Cathie Wood's Ark Invest weekly recap: adds Chinese tech names, Intellia Therapeutics

ARK Invest CEO Cathie Wood recently pointed out that the AI space is ruled by “big four” players: OpenAI, Anthropic, Elon Musk’s xAI, and Google’s (GOOG [https://seekingalpha.com/symbol/GOOG]) Gemini, describing the competition among these... Full story

Yahoo Finance • 16 days ago

Why Tempus AI Stock Is Plunging This Week

Key Points Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF. Tempus AI still holds a signif... Full story

Yahoo Finance • 20 days ago

Validea Detailed Fundamental Analysis - TEM

Below is Validea's guru fundamental report for TEMPUS AI INC (TEM). Of the 22 guru strategies we follow, TEM rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for s... Full story

Yahoo Finance • 22 days ago

TransMedics Group, Inc. (TMDX): A Bull Case Theory

We came across a bullish thesis on TransMedics Group, Inc. on Natan’s Substack. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.'s share was trading at $114.29 as of September 15th. TMDX’s trailing and... Full story

Yahoo Finance • 24 days ago

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

MarketNewsUpdates News Commentary NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to... Full story

Yahoo Finance • last month

TEM Factor-Based Stock Analysis

Below is Validea's guru fundamental report for TEMPUS AI INC (PRE-REINCORPORATION) (TEM). Of the 22 guru strategies we follow, TEM rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This... Full story

Yahoo Finance • last month

TEMPUS AI INC (NASDAQ:TEM) Excels on Minervini Trend Template with High Growth Momentum

Tempus AI Inc (NASDAQ:TEM [https://www.chartmill.com/stock/quote/TEM]) has become a notable candidate for investors using the Mark Minervini Trend Template with a high growth momentum screen. This two-part method finds stocks showing solid... Full story

Yahoo Finance • last month

Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition

Tempus AI, Inc. (NASDAQ:TEM) is one of the best Robinhood stocks to buy right now. On August 22, the company confirmed the acquisition of Paige, an artificial intelligence company specializing in digital pathology, for $81.25 million.Tempu... Full story

Yahoo Finance • 2 months ago

Should Investors Rethink Tempus AI After Shares Double and New Novartis Collaboration?

Thinking about what to do with Tempus AI shares right now? You are not alone. The stock has been full of surprises for investors looking for the next standout opportunity. After sprinting more than 120% year-to-date, Tempus AI has cemented... Full story

Yahoo Finance • 2 months ago

Can AI make clinical trials better?

Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story

Yahoo Finance • 2 months ago

Tempus AI Expands Into Digital Pathology With Paige Acquisition

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology. Tempus is a technology company focused on adopting AI to advance precision medicine. The acquisition a... Full story

Yahoo Finance • 2 months ago

Tempus AI will acquire Paige for $81.25M

[Using AI technology helps with genetic code prediction research.] Suriphon Singha/iStock via Getty Images * Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) said that it will acquire Paige, an AI company focused on digital... Full story

Yahoo Finance • 2 months ago

Tempus AI announces $81.25M acquisition of Paige

[M&A Mergers And Acquisitions] narvo vexar Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) announced [https://seekingalpha.com/pr/20209187-tempus-announces-the-acquisition-of-paige] on Friday an acquisition of the AI company... Full story

Yahoo Finance • 2 months ago

BTIG raises Tempus AI stock price target to $85 on strong Q2 growth

Investing.com - BTIG raised its price target on Tempus AI Inc (NASDAQ:TEM) to $85.00 from $75.00 while maintaining a Buy rating following the company’s strong second-quarter performance. The stock has shown impressive momentum, deliverin... Full story

Yahoo Finance • 2 months ago

Theodore Leonsis sells Tempus AI (TEM) shares worth $3.07 million

Director Theodore Leonsis sold 44,000 shares of Tempus AI, Inc. NASDAQ:TEM on August 13, 2025. The shares were sold at a price of $69.90, for a total transaction value of $3.07 million. The stock, which has surged 21% in the past week and... Full story

Yahoo Finance • 2 months ago

TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Tempus (TEM) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Tempus between August 6, 2024 an... Full story

Yahoo Finance • 2 months ago

TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or... Full story

Yahoo Finance • 2 months ago

DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 2 months ago

TEMPUS FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Tempus Investors of the August 11th Deadline and Urges Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Tempus (TEM) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Tempus between August 6, 2024 and May 27,... Full story